Literature DB >> 2709936

Speech restoration and complications of primary versus secondary tracheoesophageal puncture following total laryngectomy.

A J Maniglia1, D S Lundy, R C Casiano, S C Swim.   

Abstract

The tracheoesophageal (TE) fistula with a speech prosthesis has become the method of choice for vocal rehabilitation in many postlaryngectomy patients. Several modifications of the procedure have been described including primary TE puncture at the time of laryngectomy. Fear of increased risk of complications has kept the primary procedure from widespread usage. Our series of 95 TE fistula procedures from 1980 to 1988 revealed 33 to be primary and 62 secondary. Eighty-five percent (85%) (28 of 33) patients in the primary group achieved long-term satisfactory speech (1 year or more of follow-up). Complications occurred in 36% of this group of patients. The success rate for the secondary group was 69% (43 of 62), while the complication rate was 21%. There were no instances of death, sepsis, or mediastinitis associated with either primary or secondary TE fistula patients. It appears that the primary TE fistula can be performed as safely and effectively as the secondary procedure.

Entities:  

Mesh:

Year:  1989        PMID: 2709936     DOI: 10.1288/00005537-198905000-00004

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  9 in total

1.  [Perforation of the esophagus with a mediastinal abscess].

Authors:  K Scheuermann; K-W Delank
Journal:  HNO       Date:  2005-01       Impact factor: 1.284

2.  Influence of timing, radiation, and reconstruction on complications and speech outcomes with tracheoesophageal puncture.

Authors:  Sarah A Gitomer; Katherine A Hutcheson; Brandon L Christianson; Madeleine B Samuelson; Denise A Barringer; Dianna B Roberts; Amy C Hessel; Randal S Weber; Jan S Lewin; Mark E Zafereo
Journal:  Head Neck       Date:  2016-07-09       Impact factor: 3.147

3.  Long-term results with tracheoesophageal voice prosthesis: primary versus secondary TEP.

Authors:  Paolo Boscolo-Rizzo; Federica Zanetti; Silvia Carpené; Maria Cristina Da Mosto
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-08-23       Impact factor: 2.503

4.  Secondary tracheoesophageal puncture with in-office transnasal esophagoscopy.

Authors:  Brad LeBert; Andrew J McWhorter; Melda Kunduk; Rohan R Walvekar; Jan S Lewin; Katherine A Hutcheson; Denise A Barringer; Amy C Hessel; F Christopher Holsinger
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2009-12

5.  [Prosthetic voice rehabilitation after laryngectomy. Failures and complications after previous radiation therapy].

Authors:  P Kummer; M Chahoud; M Schuster; U Eysholdt; F Rosanowski
Journal:  HNO       Date:  2006-04       Impact factor: 1.284

6.  Incidence and predisposing factors of pharyngocutaneous fistula formation after total laryngectomy. Is there a relationship with tumor recurrence?

Authors:  Konstantinos D Markou; Konstantinos C Vlachtsis; Angelos C Nikolaou; Dimitrios G Petridis; Athanasios I Kouloulas; Ioannis C Daniilidis
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-07-10       Impact factor: 2.503

Review 7.  Post-laryngectomy voice rehabilitation with voice prosthesis: 15 years experience of the ENT Clinic of University of Catania. Retrospective data analysis and literature review.

Authors:  A Serra; P Di Mauro; D Spataro; L Maiolino; S Cocuzza
Journal:  Acta Otorhinolaryngol Ital       Date:  2015-12       Impact factor: 2.124

8.  Multivariate analysis of risk factors for pharyngocutaneous fistula after total laryngectomy.

Authors:  Paolo Boscolo-Rizzo; Giuseppe De Cillis; Carlo Marchiori; Silvia Carpenè; Maria Cristina Da Mosto
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-02-05       Impact factor: 3.236

9.  Speech rehabilitation after total laryngectomy: long-term results with indwelling voice prosthesis Blom-Singer.

Authors:  Carlos Takahiro Chone; Ana L Spina; Agricio N Crespo; Flavio M Gripp
Journal:  Braz J Otorhinolaryngol       Date:  2005-12-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.